Patent ReferencesMonoclonal antibody to human cytotoxic and suppressor T cells and methods of preparing same Monoclonal antibody to a human T cell antigen and methods of preparing same Anti-human T-lymphocyte monoclonal antibody Monoclonal antibody to human helper T cells and methods of preparing same Monoclonal antibody Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods Monoclonal antibody for human hematopoietic glycoproteins and method Human stem cells Patent #: 4714680 InventorAssigneeApplicationNo. 055942 filed on 06/01/1987US Classes:530/388.7, Binds hematopoietic cell or component or product thereof (e.g., erythrocyte granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell-surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)424/93.7, Animal or plant cell424/140.1, Extracorporeal or ex vivo removal of antibodies or immune complexes (e.g., removal of autoantibodies, etc.); or extracorporeal or ex vivo removal of antigen by antibodies (e.g., removal of cancer cells from bone marrow by antibodies, etc.)435/7.21, Animal cell435/343, Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)530/388.73, Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)530/809Fused cells, e.g., hybridoma, etc.ExaminersPrimary: Moskowitz, MargaretAssistant: Cunningham, Thomas M. Attorney, Agent or FirmInternational ClassesC12N 005/00C07K 015/00 A61K 039/00 AbstractMonoclonal antibodies that recognize a stage-specific antigen on immature human marrow cells are provided. These antibodies are useful in methods of isolating cell suspensions from human blood and marrow that can be employed in bone marrow transplantation. Cell suspensions containing human pluripotent lympho-hematopoietic stem cells are also provided, as well as therapeutic methods employing the cell suspensions.Other References
|
| ||||||||||||||